首站-论文投稿智能助手
典型文献
Homer signaling pathways as effective therapeutic targets for ischemic and traumatic brain injuries and retinal lesions
文献摘要:
Ischemic and traumatic insults to the central nervous system account for most serious acute and fatal brain injuries and are usually characterized by primary and secondary damage. Secondary damage presents the greatest challenge for medical staff; however, there are currently few effective therapeutic targets for secondary damage. Homer proteins are postsynaptic scaffolding proteins that have been implicated in ischemic and traumatic insults to the central nervous system. Homer signaling can exert either positive or negative effects during such insults, depending on the specific subtype of Homer protein. Homer 1b/c couples with other proteins to form postsynaptic densities, which form the basis of synaptic transmission, while Homer1a expression can be induced by harmful external factors. Homer 1c is used as a unique biomarker to reveal alterations in synaptic connectivity before and during the early stages of apoptosis in retinal ganglion cells, mediated or affected by extracellular or intracellular signaling or cytoskeletal processes. This review summarizes the structural features, related signaling pathways, and diverse roles of Homer proteins in physiological and pathological processes. Upregulating Homer1a or downregulating Homer1b/c may play a neuroprotective role in secondary brain injuries. Homer also plays an important role in the formation of photoreceptor synapses. These findings confirm the neuroprotective effects of Homer, and support the future design of therapeutic drug targets or gene therapies for ischemic and traumatic brain injuries and retinal disorders based on Homer proteins.
文献关键词:
作者姓名:
Xiu-Quan Wu;Ning Su;Zhou Fei;Fei Fei
作者机构:
Department of Neurosurgery,Xijing Hospital,the Fourth Military Medical University,Xi'an,Shaanxi Province,China;Department of Radiation Oncology,Xijing Hospital,the Fourth Military Medical University,Xi'an,Shaanxi Province,China;Department of Ophthalmology,Xijing Hospital,the Fourth Military MedicalUniversity,Xi'an,Shaanxi Province,China
引用格式:
[1]Xiu-Quan Wu;Ning Su;Zhou Fei;Fei Fei-.Homer signaling pathways as effective therapeutic targets for ischemic and traumatic brain injuries and retinal lesions)[J].中国神经再生研究(英文版),2022(07):1454-1461
A类:
Homer1a,Upregulating,Homer1b
B类:
signaling,pathways,effective,therapeutic,targets,ischemic,traumatic,brain,injuries,retinal,lesions,Ischemic,insults,central,nervous,system,account,most,serious,acute,fatal,are,usually,characterized,by,primary,secondary,damage,Secondary,presents,greatest,challenge,medical,staff,however,there,currently,few,proteins,postsynaptic,scaffolding,that,have,been,implicated,can,exert,either,positive,negative,effects,during,such,depending,specific,subtype,couples,other,densities,which,basis,transmission,while,expression,induced,harmful,external,factors,1c,used,unique,biomarker,reveal,alterations,connectivity,before,early,stages,apoptosis,ganglion,cells,mediated,affected,extracellular,intracellular,cytoskeletal,processes,This,review,summarizes,structural,features,related,diverse,roles,physiological,pathological,downregulating,may,neuroprotective,also,plays,important,formation,photoreceptor,synapses,These,findings,confirm,support,future,design,drug,gene,therapies,disorders
AB值:
0.51308
相似文献
Propofol postconditioning ameliorates hypoxia/reoxygenation induced H9c2 cell apoptosis and autophagy via upregulating forkhead transcription factors under hyperglycemia
Rong‑Hui Han;He‑Meng Huang;Hong Han;Hao Chen;Fei Zeng;Xiang Xie;Dan‑Yong Liu;Yin Cai;Liang‑Qing Zhang;Xin Liu;Zheng‑Yuan Xia;Jing Tang-Department of Anesthesiology,Affiliated Hospital of Guangdong Medical University,57 South Renming Avenue Xiashan District,Zhanjiang 524000,Guangdong,China;Department of Emergency,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,Guangdong,China;Department of Anesthesiology,the Eighth Affiliated Hospital,Sun Yat-Sen University,Guangzhou 518000,China;Department of Anesthesiology,Guangzhou First People's Hospital,the Second Affiliated Hospital of South China University of Technology,Guangzhou 510000,China;Department of Anesthesiology,the Second Affiliated Hospital and Yuying Children's Hospital,Wenzhou Medical University,Wenzhou 325000,Zhejiang,China;Department of Health Technology and Informatics,the Hong Kong Polytechnic University,Hung Hom 999077,Hong Kong SAR,China;State Key Laboratory of Pharmaceutical Biotechnology,Department of Medicine,the University of Hong Kong,Pok Fu Lam 999077,Hong Kong SAR,China
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis
Fang Wang;Jia-nan Wang;Xiao-yan He;Xiao-guo Suo;Chao Li;Wei-jian Ni;Yu-ting Cai;Yuan He;Xin-yun Fang;Yu-hang Dong;Tian Xing;Ya-ru Yang;Feng Zhang;Xiang Zhong;Hong-mei Zang;Ming-ming Liu;Jun Li;Xiao-ming Meng;Juan Jin-Inflammation and Immune Mediated Diseases Laboratory of Anhui Province,Anhui Institute of Innovative Drugs,School of Pharmacy,Anhui Medical University,The Key Laboratory of Anti-inflammatory of Immune Medicines,Ministry of Education,Hefei 230032,China;Department of Pharmacy,Anhui Provincial Hospital,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230001,China;Hospital of Stomatology,Anhui Medical University,Key Laboratory of Oral Diseases Research of Anhui Province,Hefei 230032,China;Department of Pharmacy,Changzheng Hospital,Naval Medical University,Shanghai 200003,China;Department of Nephrology,Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610072,China;School of Basic Medical Sciences,Anhui Medical University,Hefei 230032,China
Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury
Chao Deng;Lin Zhao;Zhi Yang;Jia-jia Shang;Chang-yu Wang;Ming-zhi Shen;Shuai Jiang;Tian Li;Wen-cheng Di;Ying Chen;He Li;Ye-dong Cheng;Yang Yang-Xi'an Key Laboratory of Cardiovascular and Cerebrovascular Diseases,Xi'an No.3 Hospital,School of Life Sciences and Medicine,Northwest University,Xi'an 710021,China;Department of Orthopaedics,Huaian Medical District of Jingling Hospital,Medical School of Nanjing University,Huaian 213001,China;Department of Cardiovascular Surgery,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China;Department of Cardiovascular Surgery,Xijing Hospital,The Fourth Military Medical University,Xi'an 710032,China;Key Laboratory of Resource Biology and Biotechnology in Western China,Ministry of Education.Life of Sciences,Northwest University,Xi'an 710021,China;Department of Cardiology,Xi'an No.3 Hospital,School of Life Sciences and Medicine,Northwest University,Xi'an 710021,China;Hainan Hospital of PLA General Hospital,The Second School of Clinical Medicine,Southern Medical University,Sanya 572013,China;National Clinical Research Center for Infectious Diseases,Shenzhen Third People's Hospital,Southern University of Science and Technology,Shenzhen 518100,China;Department of Hematology,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。